Survey							
                            
		                
		                * Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Presented by: rashmi bhatt Moderator: dr dara negi  Principle of defibrillator  Defibrillator vs cardioversion  Principle and working of pacemaker  Anesthetic implications  Functioning of ICD  Anesthetic implications of ICD  Non synchronised delivery of energy during any phase of the cardiac cycle  Indications : VT, VF, cardiac arrest due to or resulting in these  Avoided in dysarrythmias d/t digitalis toxicity or catecholamine induced overactivity  Generally under induction or sedation unless patient is hemodynamically unstable  Hand held paddles considered better than self adhesive electrodes  Types : AED, semi automated,standard with monitor and implantable  Positioning: anterolateral and anteroposterior  Anterolateral: left 4/5 ICS in midaxillary line and right sternal edge in 2/3 ICS  Anteroposterior: right sternal edge 2/3 ICS and b/w tip of left scapula and spine  Anteropost is more effective for AF and preferred in pts with implantable devices Energy wave forms: monophasic and biphasic  Biphasic: truncated and rectilinear  Biphasic is more effective and uses lesser energy  Atrial flutter: 25-50 J; AF: 50-100 J in stable patients  Polymorphic VT(unstable) or VF: 200-360 J  Monomorphic VT(stable): 100-200 J  In pediatric patients: 0.5J/kg  Complications: arrythmias(VF), thromboembolism(esp in AF), myocardial necrosis, ST elevation ( for upto 2 min), painful skin burns,hypoxia and rarely pulm oedema. Also injuries to the health care personnel.       Delivery of energy is synchronised to the large R waves or the QRS complexes Indications: SVT, AF, atrial flutter, vent tachy, reentrant tachy with hemodynamic instability Synchronization is in the early part of QRS Internal cardioversion: preceded by anticoagulation. Three temp catheters are inserted under fluoroscopic guidance. Two are used to deliver the shock and the third for R wave synchronisation and pacing. 1st in distal coronary sinus, 2nd in rt atrium appendix or lateral wall, both being connected to external defibrillator. 3rd(quadripolar) in apex of rt ventricle, connected to external pacemaker. Energy delivered is 5.6+-4.7 J. Temporary or permanent  Consists of an impulse generator and lead(s)  Leads could be transvenous or epicardial in position, uni, bi or mutipolar in no of electrodes  Unipolar: more sensitive to EMI, gas interference  Bipolar uses less energy and more resistant to interference  Placement could be transthoracic, transvenous or transesophageal  POSITION 1 Pacing chamber(s) POSITION 2 sensing chamber(s) POSITION 3 POSITION 4 response(s) programma to sensing bility POSITION 5 multisite pacing O=none O= none O= none O= none O= none A= atria A= atria I= inhibited R= rate modulation A= atria V= ventricle V= ventricle T= triggered V= ventricle D=dual(A+V) D=dual(A+V) D=dual(I+T) D=dual(A+V)  Indications: sinus node disease, av node disease, long QT syndrome, HOCM, DCM  Magnet behaviour: not all devices are sensitive  Magnet response: IFI/ERI/EOL  Some pacemakers carry out TMT  Pacemaker induced tachycardia       Pre op: optimise coexisting diseases, CXR, reprogramming (to prevent oversensing). Spl considerations in lithotripsy, hysteroscopy, chest/abd procedures, TURP,ECT etc. intraop: ecg filtering disabled, avoid monopolar ESU, equipment for pacing, defibrillation to be ready. Post op: reprogramming and reinterrogation. Pacemaker failure: generator failure, lead failure, failure of capture Failure of capture may result from increase in the threshold for capture Correction by magnet application, temporary pacing, sympathomimetic drugs(epi/dopa).  Important to differentiate from other thoracic devices esp pacemaker in v/o electromagnetic interference(EMI)  Previously placed in an abdominal pocket; present day pectoral placement  Can be differentiated using a CXR to examine the RV lead system.  Other devices could be for pain control, thalamic stimulation to control PD, phrenic nerve stimulation, vagus stimulation for epilepsy, depression, heart failure and obesity.         Battery powered device to deliver energy in form of shock to terminate VT/VF Believed to be superior to drug therapy in pt with EF<35% Average life of 3-6 years Principle: measures R-R interval and categorises as normal, fast or slow. Programmed to confirm VT/VF to avoid inappropriate therapy(mc SVT) Delivers 6-18 shocks per minute Programmed to diff VT from SVT by onset, stability, QRS width, AV synchrony and waveform In case of slow R-R, antibradycardia pacing Position I: Shock Position II: Chambers(s) Antitachycardia Pacing Chamber(s) Position III: Tachycardia Detection Position IV: Antibradycardia Pacing Chamber(s) * O= none O= none E= electrogram A= atrium A= atrium H= hemodynamic V= ventricle V= ventricle V= ventricle D= dual (A + V) D= dual (A + V) D= dual (A + V) A= atrium Tranvenous or endocardial approach Surgical or Epicardial approach  Indications: vent tachy, vent fib, pts awaiting heart transplant, long QT syndrome, brugada syndrome, RV dysplasia.  Prophylactic role in HOCM, post MI with EF<30%  Magnet behaviour: suspension pf antitachycardia pacing. Generally no effect on antibradycardia pacing.  Pre op: optimisation of coexisting conditions checking of battery life disable antitachycardia therapy CXR to confirm position of RV lead  Intra op: ecg monitoring facility to deliver external cardioversion/defibrillation  Post op: reinterrogation and reenabling